We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Calando Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer

News   Mar 19, 2008

 
Calando Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer
 
 
 

RELATED ARTICLES

Discovery of Novel Genes May Lead to New Therapies for Muscle Cancer

News

Scientists have uncovered a unique set of genes that play a role in muscle cellular gene expression and differentiation which could lead to new therapeutic targets to prevent the spread of muscle cancer.

READ MORE

Making Light of the Raman Dance of Solids

News

Scientists investigated the excitation and detection of photogenerated coherent phonons in polar semiconductor GaAs through an ultrafast dual pump-probe laser for quantum interferometry.

READ MORE

Why Not Catching Enough Zzz’s Is Bad for Your Heart

News

In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE